{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:45:59Z","timestamp":1794566759965,"version":"4.9.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-58370-9","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T19:23:48Z","timestamp":1743794628000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Epigenetic mechanisms controlling human leukemia stem cells and therapy resistance"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5573-1677","authenticated-orcid":false,"given":"Sumiko","family":"Takao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7071-1030","authenticated-orcid":false,"given":"Victor","family":"Morell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8418-0743","authenticated-orcid":false,"given":"Masahiro","family":"Uni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Slavit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Rha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6080-6175","authenticated-orcid":false,"given":"Laura K.","family":"Schmalbrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona C.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3773-8239","authenticated-orcid":false,"given":"Sergi","family":"Beneyto-Calabuig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6820-5083","authenticated-orcid":false,"given":"Richard P.","family":"Koche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1233-5874","authenticated-orcid":false,"given":"Lars","family":"Velten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8063-9191","authenticated-orcid":false,"given":"Alex","family":"Kentsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"58370_CR1","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/367645a0","volume":"367","author":"T Lapidot","year":"1994","unstructured":"Lapidot, T. et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367, 645\u2013648 (1994).","journal-title":"Nature"},{"key":"58370_CR2","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nm0797-730","volume":"3","author":"D Bonnet","year":"1997","unstructured":"Bonnet, D. & Dick, J. E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3, 730\u2013737 (1997).","journal-title":"Nat. Med."},{"key":"58370_CR3","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ccr.2010.12.012","volume":"19","author":"N Goardon","year":"2011","unstructured":"Goardon, N. et al. Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia. Cancer Cell 19, 138\u2013152 (2011).","journal-title":"Cancer Cell"},{"key":"58370_CR4","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1172\/JCI41495","volume":"121","author":"J-E Sarry","year":"2011","unstructured":"Sarry, J.-E. et al. Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD\/SCID\/IL2R\u03b3c-deficient mice. J. Clin. Invest. 121, 384\u2013395 (2011).","journal-title":"J. Clin. Invest."},{"key":"58370_CR5","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1101\/gad.349368.122","volume":"36","author":"JP Bewersdorf","year":"2022","unstructured":"Bewersdorf, J. P. & Abdel-Wahab, O. Translating recent advances in the pathogenesis of acute myeloid leukemia to the clinic. Genes Dev. 36, 259\u2013277 (2022).","journal-title":"Genes Dev."},{"key":"58370_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","volume":"36","author":"RM Shallis","year":"2019","unstructured":"Shallis, R. M., Wang, R., Davidoff, A., Ma, X. & Zeidan, A. M. Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges. Blood Rev. 36, 70\u201387 (2019).","journal-title":"Blood Rev."},{"key":"58370_CR7","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil, E. et al. Genomic classification and prognosis in acute myeloid leukemia. N. Engl. J. Med. 374, 2209\u20132221 (2016).","journal-title":"N. Engl. J. Med."},{"key":"58370_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41586-021-04206-7","volume":"601","author":"KA Fennell","year":"2022","unstructured":"Fennell, K. A. et al. Non-genetic determinants of malignant clonal fitness at single-cell resolution. Nature 601, 125\u2013131 (2022).","journal-title":"Nature"},{"key":"58370_CR9","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1182\/blood.2020009103","volume":"137","author":"I Iacobucci","year":"2021","unstructured":"Iacobucci, I. et al. Modeling and targeting of erythroleukemia by hematopoietic genome editing. Blood 137, 1628\u20131640 (2021).","journal-title":"Blood"},{"key":"58370_CR10","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.stem.2017.07.015","volume":"21","author":"Z Tothova","year":"2017","unstructured":"Tothova, Z. et al. Multiplex CRISPR\/Cas9-based genome editing in human hematopoietic stem cells models clonal hematopoiesis and myeloid neoplasia. Cell Stem Cell 21, 547\u2013555.e8 (2017).","journal-title":"Cell Stem Cell"},{"key":"58370_CR11","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1182\/blood.2021012519","volume":"139","author":"X You","year":"2022","unstructured":"You, X. et al. Asxl1 loss cooperates with oncogenic Nras in mice to reprogram the immune microenvironment and drive leukemic transformation. Blood 139, 1066\u20131079 (2022).","journal-title":"Blood"},{"key":"58370_CR12","doi-asserted-by":"publisher","first-page":"4842","DOI":"10.1182\/bloodadvances.2020003958","volume":"5","author":"R D\u00edaz de la Guardia","year":"2021","unstructured":"D\u00edaz de la Guardia, R. et al. Engraftment characterization of risk-stratified AML in NSGS mice. Blood Adv. 5, 4842\u20134854 (2021).","journal-title":"Blood Adv."},{"key":"58370_CR13","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/ijc.28170","volume":"133","author":"J Woiterski","year":"2013","unstructured":"Woiterski, J. et al. Engraftment of low numbers of pediatric acute lymphoid and myeloid leukemias into NOD\/SCID\/IL2Rc\u03b3null mice reflects individual leukemogenecity and highly correlates with clinical outcome. Int. J. Cancer 133, 1547\u20131556 (2013).","journal-title":"Int. J. Cancer"},{"key":"58370_CR14","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1158\/0008-5472.CAN-15-2063","volume":"76","author":"E Griessinger","year":"2016","unstructured":"Griessinger, E. et al. Frequency and dynamics of leukemia-initiating cells during short-term ex vivo culture informs outcomes in acute myeloid leukemia patients. Cancer Res. 76, 2082\u20132086 (2016).","journal-title":"Cancer Res."},{"key":"58370_CR15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/nbt.1517","volume":"27","author":"A Foudi","year":"2009","unstructured":"Foudi, A. et al. Analysis of histone 2B-GFP retention reveals slowly cycling hematopoietic stem cells. Nat. Biotechnol. 27, 84\u201390 (2009).","journal-title":"Nat. Biotechnol."},{"key":"58370_CR16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.stemcr.2014.01.016","volume":"2","author":"J Qiu","year":"2014","unstructured":"Qiu, J., Papatsenko, D., Niu, X., Schaniel, C. & Moore, K. Divisional history and hematopoietic stem cell function during homeostasis. Stem Cell Rep. 2, 473\u2013490 (2014).","journal-title":"Stem Cell Rep."},{"key":"58370_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1084\/jem.20101643","volume":"208","author":"H Takizawa","year":"2011","unstructured":"Takizawa, H., Regoes, R. R., Boddupalli, C. S., Bonhoeffer, S. & Manz, M. G. Dynamic variation in cycling of hematopoietic stem cells in steady state and inflammation. J. Exp. Med. 208, 273\u2013284 (2011).","journal-title":"J. Exp. Med."},{"key":"58370_CR18","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.cell.2008.10.048","volume":"135","author":"A Wilson","year":"2008","unstructured":"Wilson, A. et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 135, 1118\u20131129 (2008).","journal-title":"Cell"},{"key":"58370_CR19","doi-asserted-by":"publisher","unstructured":"Ebinger, S. et al. Characterization of rare, dormant, and therapy-resistant cells in acute lymphoblastic leukemia. Cancer Cell https:\/\/doi.org\/10.1016\/j.ccell.2016.11.002 (2016).","DOI":"10.1016\/j.ccell.2016.11.002"},{"key":"58370_CR20","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.3324\/haematol.2019.226282","volume":"105","author":"S Ebinger","year":"2020","unstructured":"Ebinger, S. et al. Plasticity in growth behavior of patients\u2019 acute myeloid leukemia stem cells growing in mice. Haematologica 105, 2855\u20132860 (2020).","journal-title":"Haematologica"},{"key":"58370_CR21","doi-asserted-by":"publisher","unstructured":"Eddaoudi, A., Canning, S. L. & Kato, I. Flow cytometric detection of G0 in live cells by hoechst 33342 and pyronin Y Staining. In: Cellular Quiescence: Methods and Protocols (ed. Lacorazza, H. D.) 49\u201357 (Springer, New York, NY, https:\/\/doi.org\/10.1007\/978-1-4939-7371-2_3 2018).","DOI":"10.1007\/978-1-4939-7371-2_3"},{"key":"58370_CR22","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.celrep.2019.03.009","volume":"27","author":"B Adane","year":"2019","unstructured":"Adane, B. et al. The hematopoietic oxidase NOX2 regulates self-renewal of leukemic stem cells. Cell Rep. 27, 238\u2013254.e6 (2019).","journal-title":"Cell Rep."},{"key":"58370_CR23","doi-asserted-by":"publisher","first-page":"100248","DOI":"10.1016\/j.xpro.2020.100248","volume":"2","author":"BM Stevens","year":"2021","unstructured":"Stevens, B. M., O\u2019Brien, C., Jordan, C. T. & Jones, C. L. Enriching for human acute myeloid leukemia stem cells using reactive oxygen species-based cell sorting. STAR Protoc. 2, 100248 (2021).","journal-title":"STAR Protoc."},{"key":"58370_CR24","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1182\/blood-2012-10-464677","volume":"121","author":"M Wunderlich","year":"2013","unstructured":"Wunderlich, M. et al. AML cells are differentially sensitive to chemotherapy treatment in a human xenograft model. Blood 121, e90\u2013e97 (2013).","journal-title":"Blood"},{"key":"58370_CR25","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1158\/2159-8290.CD-17-0613","volume":"7","author":"C Grommes","year":"2017","unstructured":"Grommes, C. et al. Ibrutinib unmasks critical role of bruton tyrosine kinase in primary CNS lymphoma. Cancer Discov. 7, 1018\u20131029 (2017).","journal-title":"Cancer Discov."},{"key":"58370_CR26","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41586-020-2864-x","volume":"587","author":"LA Miles","year":"2020","unstructured":"Miles, L. A. et al. Single-cell mutation analysis of clonal evolution in myeloid malignancies. Nature 587, 477\u2013482 (2020).","journal-title":"Nature"},{"key":"58370_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/leu.2016.160","volume":"31","author":"Q-Y Sun","year":"2017","unstructured":"Sun, Q.-Y. et al. Ordering of mutations in acute myeloid leukemia with partial tandem duplication of MLL (MLL-PTD). Leukemia 31, 1\u201310 (2017).","journal-title":"Leukemia"},{"key":"58370_CR28","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1182\/blood.2020007626","volume":"137","author":"LK Schmalbrock","year":"2021","unstructured":"Schmalbrock, L. K. et al. Clonal evolution of acute myeloid leukemia with FLT3-ITD mutation under treatment with midostaurin. Blood 137, 3093\u20133104 (2021).","journal-title":"Blood"},{"key":"58370_CR29","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.stem.2010.07.016","volume":"7","author":"NK Wilson","year":"2010","unstructured":"Wilson, N. K. et al. Combinatorial transcriptional control in blood stem\/progenitor cells: genome-wide analysis of ten major transcriptional regulators. Cell Stem Cell 7, 532\u2013544 (2010).","journal-title":"Cell Stem Cell"},{"key":"58370_CR30","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1182\/blood-2012-07-446120","volume":"121","author":"E Diffner","year":"2013","unstructured":"Diffner, E. et al. Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia. Blood 121, 2289\u20132300 (2013).","journal-title":"Blood"},{"key":"58370_CR31","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.cell.2004.10.010","volume":"119","author":"E Passegu\u00e9","year":"2004","unstructured":"Passegu\u00e9, E., Wagner, E. F. & Weissman, I. L. JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells. Cell 119, 431\u2013443 (2004).","journal-title":"Cell"},{"key":"58370_CR32","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ccr.2009.02.016","volume":"15","author":"M Santaguida","year":"2009","unstructured":"Santaguida, M. et al. JunB protects against myeloid malignancies by limiting hematopoietic stem cell proliferation and differentiation without affecting self-renewal. Cancer Cell 15, 341\u2013352 (2009).","journal-title":"Cancer Cell"},{"key":"58370_CR33","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1182\/blood.2018875922","volume":"134","author":"CS Park","year":"2019","unstructured":"Park, C. S. et al. A KLF4-DYRK2\u2013mediated pathway regulating self-renewal in CML stem cells. Blood 134, 1960\u20131972 (2019).","journal-title":"Blood"},{"key":"58370_CR34","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1182\/blood-2011-06-359406","volume":"119","author":"G Bungartz","year":"2012","unstructured":"Bungartz, G., Land, H., Scadden, D. T. & Emerson, S. G. NF-Y is necessary for hematopoietic stem cell proliferation and survival. Blood 119, 1380\u20131389 (2012).","journal-title":"Blood"},{"key":"58370_CR35","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.stem.2020.12.005","volume":"28","author":"E Wang","year":"2021","unstructured":"Wang, E. et al. Surface antigen-guided CRISPR screens identify regulators of myeloid leukemia differentiation. Cell Stem Cell 28, 718\u2013731.e6 (2021).","journal-title":"Cell Stem Cell"},{"key":"58370_CR36","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0092-8674(00)00025-8","volume":"102","author":"N Takakura","year":"2000","unstructured":"Takakura, N. et al. A role for hematopoietic stem cells in promoting angiogenesis. Cell 102, 199\u2013209 (2000).","journal-title":"Cell"},{"key":"58370_CR37","doi-asserted-by":"publisher","first-page":"e05521","DOI":"10.7554\/eLife.05521","volume":"4","author":"BO Zhou","year":"2015","unstructured":"Zhou, B. O., Ding, L. & Morrison, S. J. Hematopoietic stem and progenitor cells regulate the regeneration of their niche by secreting angiopoietin-1. eLife 4, e05521 (2015).","journal-title":"eLife"},{"key":"58370_CR38","doi-asserted-by":"publisher","first-page":"D1138","DOI":"10.1093\/nar\/gkad993","volume":"52","author":"MH G\u00edslason","year":"2024","unstructured":"G\u00edslason, M. H. et al. BloodSpot 3.0: a database of gene and protein expression data in normal and malignant haematopoiesis. Nucleic Acids Res. 52, D1138\u2013D1142 (2024).","journal-title":"Nucleic Acids Res."},{"key":"58370_CR39","doi-asserted-by":"publisher","unstructured":"Arceci, R. J., Berman, J. N. & Meshinchi, S. Chapter 17 - acute myeloid leukemia. In: Cancer Genomics (eds. Dellaire, G., Berman, J. N. & Arceci, R. J.) 283\u2013300 (Academic Press, Boston, https:\/\/doi.org\/10.1016\/B978-0-12-396967-5.00017-7 2014).","DOI":"10.1016\/B978-0-12-396967-5.00017-7"},{"key":"58370_CR40","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.cell.2017.04.018","volume":"169","author":"N Cabezas-Wallscheid","year":"2017","unstructured":"Cabezas-Wallscheid, N. et al. Vitamin A-retinoic acid signaling regulates hematopoietic stem cell dormancy. Cell 169, 807\u2013823.e19 (2017).","journal-title":"Cell"},{"key":"58370_CR41","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1101\/gad.313104","volume":"18","author":"A Wilson","year":"2004","unstructured":"Wilson, A. et al. c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev. 18, 2747\u20132763 (2004).","journal-title":"Genes Dev."},{"key":"58370_CR42","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1016\/j.stem.2021.07.003","volume":"28","author":"L Garc\u00eda-Prat","year":"2021","unstructured":"Garc\u00eda-Prat, L. et al. TFEB-mediated endolysosomal activity controls human hematopoietic stem cell fate. Cell Stem Cell 28, 1838\u20131850.e10 (2021).","journal-title":"Cell Stem Cell"},{"key":"58370_CR43","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nature13035","volume":"509","author":"RAJ Signer","year":"2014","unstructured":"Signer, R. A. J., Magee, J. A., Salic, A. & Morrison, S. J. Haematopoietic stem cells require a highly regulated protein synthesis rate. Nature 509, 49\u201354 (2014).","journal-title":"Nature"},{"key":"58370_CR44","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","volume":"176","author":"P van Galen","year":"2019","unstructured":"Galen, P. van et al. Single-cell RNA-seq reveals AML hierarchies relevant to disease progression and immunity. Cell 176, 1265\u20131281.e24 (2019).","journal-title":"Cell"},{"key":"58370_CR45","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1158\/2159-8290.CD-20-1375","volume":"11","author":"C Duy","year":"2021","unstructured":"Duy, C. et al. Chemotherapy induces senescence-like resilient cells capable of initiating AML recurrence. Cancer Discov. 11, 1542\u20131561 (2021).","journal-title":"Cancer Discov."},{"key":"58370_CR46","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ccell.2018.08.007","volume":"34","author":"AL Boyd","year":"2018","unstructured":"Boyd, A. L. et al. Identification of chemotherapy-induced leukemic-regenerating cells reveals a transient vulnerability of human AML recurrence. Cancer Cell 34, 483\u2013498.e5 (2018).","journal-title":"Cancer Cell"},{"key":"58370_CR47","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","volume":"7","author":"T Farge","year":"2017","unstructured":"Farge, T. et al. Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism. Cancer Discov. 7, 716\u2013735 (2017).","journal-title":"Cancer Discov."},{"key":"58370_CR48","doi-asserted-by":"crossref","unstructured":"Morris, V. et al. Hypoxic, glycolytic metabolism is a vulnerability of B-acute lymphoblastic leukemia-initiating cells. Cell Rep. 39, 110752 (2022).","DOI":"10.1016\/j.celrep.2022.110752"},{"key":"58370_CR49","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/nm.2415","volume":"17","author":"K Eppert","year":"2011","unstructured":"Eppert, K. et al. Stem cell gene expression programs influence clinical outcome in human leukemia. Nat. Med. 17, 1086\u20131093 (2011).","journal-title":"Nat. Med."},{"key":"58370_CR50","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nature20598","volume":"540","author":"SWK Ng","year":"2016","unstructured":"Ng, S. W. K. et al. A 17-gene stemness score for rapid determination of risk in acute leukaemia. Nature 540, 433\u2013437 (2016).","journal-title":"Nature"},{"key":"58370_CR51","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1001\/jama.2010.1862","volume":"304","author":"AJ Gentles","year":"2010","unstructured":"Gentles, A. J., Plevritis, S. K., Majeti, R. & Alizadeh, A. A. Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia. JAMA 304, 2706\u20132715 (2010).","journal-title":"JAMA"},{"key":"58370_CR52","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1038\/sj.leu.2404401","volume":"20","author":"H Gal","year":"2006","unstructured":"Gal, H. et al. Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cells. Leukemia 20, 2147\u20132154 (2006).","journal-title":"Leukemia"},{"key":"58370_CR53","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.stem.2023.04.001","volume":"30","author":"S Beneyto-Calabuig","year":"2023","unstructured":"Beneyto-Calabuig, S. et al. Clonally resolved single-cell multi-omics identifies routes of cellular differentiation in acute myeloid leukemia. Cell Stem Cell 30, 706\u2013721.e8 (2023).","journal-title":"Cell Stem Cell"},{"key":"58370_CR54","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk, D. et al. The STRING database in 2021: customizable protein\u2013protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res. 49, D605\u2013D612 (2021).","journal-title":"Nucleic Acids Res."},{"key":"58370_CR55","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1093\/nar\/gku936","volume":"42","author":"EK Brinkman","year":"2014","unstructured":"Brinkman, E. K., Chen, T., Amendola, M. & van Steensel, B. Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res. 42, e168 (2014).","journal-title":"Nucleic Acids Res."},{"key":"58370_CR56","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189\u2013196 (2016).","journal-title":"Science"},{"key":"58370_CR57","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1038\/s41590-021-01059-0","volume":"22","author":"S Triana","year":"2021","unstructured":"Triana, S. et al. Single-cell proteo-genomic reference maps of the hematopoietic system enable the purification and massive profiling of precisely defined cell states. Nat. Immunol. 22, 1577\u20131589 (2021).","journal-title":"Nat. Immunol."},{"key":"58370_CR58","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1158\/2159-8290.CD-22-1297","volume":"13","author":"S Pei","year":"2023","unstructured":"Pei, S. et al. A novel type of monocytic leukemia stem cell revealed by the clinical use of venetoclax-based therapy. Cancer Discov. 13, 2032\u20132049 (2023).","journal-title":"Cancer Discov."},{"key":"58370_CR59","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41586-024-08137-x","volume":"636","author":"J Sango","year":"2024","unstructured":"Sango, J. et al. RAS-mutant leukaemia stem cells drive clinical resistance to venetoclax. Nature 636, 241\u2013250 (2024).","journal-title":"Nature"},{"key":"58370_CR60","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083\u20131086 (2017).","journal-title":"Nat. Methods"},{"key":"58370_CR61","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1038\/s41596-020-0336-2","volume":"15","author":"B Van de Sande","year":"2020","unstructured":"Van de Sande, B. et al. A scalable SCENIC workflow for single-cell gene regulatory network analysis. Nat. Protoc. 15, 2247\u20132276 (2020).","journal-title":"Nat. Protoc."},{"key":"58370_CR62","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.devcel.2021.12.007","volume":"57","author":"XP Xie","year":"2022","unstructured":"Xie, X. P. et al. Quiescent human glioblastoma cancer stem cells drive tumor initiation, expansion, and recurrence following chemotherapy. Dev. Cell 57, 32\u201346.e8 (2022).","journal-title":"Dev. Cell"},{"key":"58370_CR63","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1101\/gad.282756.116","volume":"30","author":"RAJ Signer","year":"2016","unstructured":"Signer, R. A. J. et al. The rate of protein synthesis in hematopoietic stem cells is limited partly by 4E-BPs. Genes Dev. 30, 1698\u20131703 (2016).","journal-title":"Genes Dev."},{"key":"58370_CR64","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.cell.2016.06.042","volume":"166","author":"KA Goncalves","year":"2016","unstructured":"Goncalves, K. A. et al. Angiogenin promotes hematopoietic regeneration by dichotomously regulating quiescence of stem and progenitor cells. Cell 166, 894\u2013906 (2016).","journal-title":"Cell"},{"key":"58370_CR65","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.celrep.2019.12.003","volume":"30","author":"LHS Jose","year":"2020","unstructured":"Jose, L. H. S. et al. Modest declines in proteome quality impair hematopoietic stem cell self-renewal. Cell Rep. 30, 69\u201380.e6 (2020).","journal-title":"Cell Rep."},{"key":"58370_CR66","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.celrep.2018.10.021","volume":"25","author":"P van Galen","year":"2018","unstructured":"Galen, P. van et al. Integrated stress response activity marks stem cells in normal hematopoiesis and leukemia. Cell Rep. 25, 1109\u20131117.e5 (2018).","journal-title":"Cell Rep."},{"key":"58370_CR67","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature22993","volume":"547","author":"LI Shlush","year":"2017","unstructured":"Shlush, L. I. et al. Tracing the origins of relapse in acute myeloid leukaemia to stem cells. Nature 547, 104\u2013108 (2017).","journal-title":"Nature"},{"key":"58370_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2015.08.003","volume":"21\u201322","author":"S Blatter","year":"2015","unstructured":"Blatter, S. & Rottenberg, S. Minimal residual disease in cancer therapy \u2013 small things make all the difference. Drug Resist. Updat. 21\u201322, 1\u201310 (2015).","journal-title":"Drug Resist. Updat."},{"key":"58370_CR69","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/nbt1350","volume":"25","author":"F Ishikawa","year":"2007","unstructured":"Ishikawa, F. et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat. Biotechnol. 25, 1315\u20131321 (2007).","journal-title":"Nat. Biotechnol."},{"key":"58370_CR70","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.stem.2021.02.013","volume":"28","author":"CL Jones","year":"2021","unstructured":"Jones, C. L., Inguva, A. & Jordan, C. T. Targeting energy metabolism in cancer stem cells: progress and challenges in leukemia and solid tumors. Cell Stem Cell 28, 378\u2013393 (2021).","journal-title":"Cell Stem Cell"},{"key":"58370_CR71","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.stem.2016.06.001","volume":"19","author":"H Ye","year":"2016","unstructured":"Ye, H. et al. Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche. Cell Stem Cell 19, 23\u201337 (2016).","journal-title":"Cell Stem Cell"},{"key":"58370_CR72","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.65905","volume":"10","author":"S Takao","year":"2021","unstructured":"Takao, S. et al. Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia. eLife 10, e65905 (2021).","journal-title":"eLife"},{"key":"58370_CR73","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1158\/2159-8290.CD-20-1793","volume":"11","author":"L Smeenk","year":"2021","unstructured":"Smeenk, L. et al. Selective requirement of MYB for oncogenic hyperactivation of a translocated enhancer in leukemia. Cancer Discov. 11, 2868\u20132883 (2021).","journal-title":"Cancer Discov."},{"key":"58370_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).","journal-title":"Nat. Commun."},{"key":"58370_CR75","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth.4644","volume":"15","author":"VY Kiselev","year":"2018","unstructured":"Kiselev, V. Y., Yiu, A. & Hemberg, M. scmap: projection of single-cell RNA-seq data across data sets. Nat. Methods 15, 359\u2013362 (2018).","journal-title":"Nat. Methods"},{"key":"58370_CR76","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.stem.2008.11.015","volume":"4","author":"TCP Somervaille","year":"2009","unstructured":"Somervaille, T. C. P. et al. Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells. Cell Stem Cell 4, 129\u2013140 (2009).","journal-title":"Cell Stem Cell"},{"key":"58370_CR77","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0844-5","volume":"16","author":"G Finak","year":"2015","unstructured":"Finak, G. et al. MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data. Genome Biol. 16, 278 (2015).","journal-title":"Genome Biol."},{"key":"58370_CR78","unstructured":"Shen L., Sinai ISoMaM. GeneOverlap: test and visualize gene overlaps. R package1017 version 1.32.0, http:\/\/shenlab-sinai.github.io\/shenlab-sinai\/ (2022)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58370-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58370-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58370-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T16:11:12Z","timestamp":1743869472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58370-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["58370"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-58370-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.09.22.509005","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"9 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests. A.K. is a consultant to Rgenta, Novartis, Blueprint Medicines, and Syndax.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3196"}}